45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
1,844
Insurances with rates
20
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| Signs & symptoms with major complications | Signs & symptoms with major complications | $108,590 | $108,590 | — | — | 2 |
| General symptoms of illness such as fever, pain, | General symptoms of illness such as fever, pain, shortness of breath | $88,429 | $88,429 | — | — | 2 |
| Brain contusion/laceration & complicated skull F | Brain contusion/laceration & complicated skull Fx, coma < 1 hr or no coma [Minor Severity] | $86,115 | $86,115 | — | — | 1 |
| Fractures of hip & pelvis without major complica | Fractures of hip & pelvis without major complications | $80,837 | $80,837 | — | — | 2 |
| Craniotomy for trauma [Catastrophic Severity] | Craniotomy for trauma [Catastrophic Severity] | $79,434 | $79,434 | — | — | 1 |
| Respiratory infections and inflammations with ma | Respiratory infections and inflammations with major complications | $71,125 | $71,125 | — | — | 1 |
| Other disorders of nervous system with complicat | Other disorders of nervous system with complications | $68,351 | $68,351 | — | — | 1 |
| Total Knee or Hip Replacement | Total Knee or Hip Replacement | $47,767 | $47,767 | — | — | 1 |
| 9108494 | 50242-0085-27 - alteplase 100 mg intravenous injection [EXSP] | $38,058 | $38,058 | — | — | 2 |
| Chronic Lung Disease with major complications | Chronic Lung Disease with major complications | $35,549 | $35,549 | — | — | 1 |
| 9109518 | 64764-0300-20 - vedolizumab 300 mg intravenous injection [EXSP] | $35,360 | $35,360 | — | — | 6 |
| Disorders of pancreas except malignancy without | Disorders of pancreas except malignancy without complications | $34,941 | $34,941 | — | — | 1 |
| 9109176 | 00078-0825-81 - octreotide 30 mg intramuscular injection, extended release [EXSP] | $28,180 | $28,180 | — | — | 2 |
| Infection of the skin | Infection of the skin | $27,137 | $27,137 | — | — | 1 |
| Respiratory Failure | Respiratory Failure | $25,435 | $25,435 | — | — | 1 |
| 9108641 | 50474-0710-79 - certolizumab 200 mg/mL subcutaneous kit [EXSP] | $23,370 | $23,370 | — | — | 4 |
| 9109175 | 00078-0818-81 - octreotide 20 mg intramuscular injection, extended release [EXSP] | $18,832 | $18,832 | — | — | 2 |
| Ungroupable Inpatient Condition | Ungroupable Inpatient Condition | $18,596 | $18,596 | — | — | 2 |
| Degenerative nervous system disorders without co | Degenerative nervous system disorders without complications | $18,390 | $18,390 | — | — | 2 |
| Migraine & other headaches [Minor Severity] | Migraine & other headaches [Minor Severity] | $17,832 | $17,832 | — | — | 1 |
| Esophagitis, gastroent & misc digest disorders w | Esophagitis, gastroent & misc digest disorders with major complications | $17,536 | $17,536 | — | — | 1 |
| Pulmonary embolism with major complications | Pulmonary embolism with major complications | $16,660 | $16,660 | — | — | 1 |
| 9200082 | 00069-0249-01 - riTUXimab pvvr 10 mg/mL Sol [EXSP] | $15,578 | $15,578 | — | — | 2 |
| Mental Illness [MSDRG 885] | Mental Illness [MSDRG 885] | $14,093 | $14,093 | — | — | 1 |
| 9108700 | 55513-0730-01 - denosumab 120 mg/1.7 mL subcutaneous solution 1.7 mL [EXSP] | $12,471 | $12,471 | — | — | 10 |
| 9956631 | 13533-0318-03 - rabies immune globulin, human 300 intl units/mL injectable solution 3 mL [EXSP] | $8,729 | $8,729 | — | — | 2 |
| 10087255 | 55513-0710-21 - denosumab 60 mg/mL subcutaneous solution 1 mL [EXSP] | $8,142 | $8,142 | — | — | 10 |
| 8231157 | ROOM/BED: Inpatient | $7,972 | $7,972 | — | — | 9 |
| 9108699 | 55513-0710-01 - denosumab 60 mg/mL subcutaneous solution 1 mL [EXSP] | $6,798 | $6,798 | — | — | 10 |
| 9108881 | 59676-0820-01 - hyaluronan 88 mg/4 mL intra-articular solution 4 mL [EXSP] | $6,688 | $6,688 | — | — | 2 |
| 9108883 | 58468-0090-03 - hylan G-F 20 48 mg/6 mL intra-articular solution 6 mL [EXSP] | $5,957 | $5,957 | — | — | 2 |
| 9108468 | 00003-2187-13 - abatacept 250 mg intravenous injection [EXSP] | $5,861 | $5,861 | — | — | 4 |
| 8337656 | 43249 Esophagogastroduodenoscopy, flexible, transoral; with transendoscopic balloon dilation of esop | $5,706 | $5,706 | — | — | 1 |
| 9108807 | 00517-0650-01 - ferric carboxymaltose (as elemental iron) 50 mg/mL intravenous solution 15 mL [EXSP] | $5,581 | $5,581 | — | — | 6 |
| 9929898 | 55513-0998-02 - romosozumab-aqqg 105 mg/1.17 mL subcutaneous solution 1.17 mL [EXSP] | $5,448 | $5,448 | — | — | 4 |
| 2644301 | 99285 - Level 5 | $5,388 | $5,388 | — | — | 18 |
| 8345561 | 99285 EMERGENCY DEPT VISIT HIGH SEVERITY&THREAT FUNCJ Tech Fee | $5,388 | $5,388 | — | — | 18 |
| 8696679 | .HCV RT-PCR, Quant (Non-Graph) 550362 LC | $5,383 | $5,383 | — | — | 4 |
| 8085548 | ROOM/BED: Swing Bed | $5,133 | $5,133 | — | — | 9 |
| 8554707 | 60 mg/1ml inj denosumab - AMB denosumab Charge | $4,982 | $4,982 | — | — | 5 |
| 1168836 | MRI Elbow w/ + w/o Contrast Left | $4,878 | $4,878 | — | — | 1 |
| 1168838 | MRI Elbow w/ + w/o Contrast Right | $4,878 | $4,878 | — | — | 1 |
| 1169032 | MRI Shoulder w/ + w/o Contrast Left | $4,878 | $4,878 | — | — | 1 |
| 1169034 | MRI Shoulder w/ + w/o Contrast Right | $4,878 | $4,878 | — | — | 1 |
| 1169128 | MRI Wrist w/ + w/o Contrast Left | $4,878 | $4,878 | — | — | 1 |
| 1169130 | MRI Wrist w/ + w/o Contrast Right | $4,878 | $4,878 | — | — | 1 |
| 9109350 | 55513-0880-02 - romosozumab-aqqg 105 mg/1.17 mL subcutaneous solution 1.17 mL [EXSP] | $4,862 | $4,862 | — | — | 4 |
| 8060002 | MRI Forearm w/ + w/o Contrast Left | $4,727 | $4,727 | — | — | 4 |
| 8060004 | MRI Forearm w/ + w/o Contrast Right | $4,727 | $4,727 | — | — | 4 |
| 1168920 | MRI Hand w/ + w/o Contrast Right | $4,727 | $4,727 | — | — | 4 |
Showing top 50 of 1,844 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.